Trials / Completed
CompletedNCT03775655
Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section
Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section: Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate the effectiveness of low dose scheme with dexmedetomidine as an adjuvant. Taking in consideration optimum intraoperative surgical conditions, best post-operative pain free experience, and more stable hemodynamic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | 10μg dexmedetomidine will be added to the injectate to be injected intrathecally |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2019-01-10
- Completion
- 2019-01-10
- First posted
- 2018-12-14
- Last updated
- 2019-01-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03775655. Inclusion in this directory is not an endorsement.